# Ocular Diseases and Behçet’s Syndrome

**Type:** Topics  
**Canonical URL:** https://scholariq.org/topics/ocular-diseases-and-behcet-s-syndrome/

## Facts

| Field | Value |
| --- | --- |
| Description | This cluster of papers focuses on the epidemiology, diagnosis, and management of ocular inflammatory diseases, particularly uveitis and Behçet's disease. It covers topics such as the use of immunosuppressive drugs, anti-TNF therapy, and interferon alpha2a therapy in the treatment of these conditions. Additionally, it discusses the epidemiological patterns and prevalence of ocular inflammatory diseases, including their association with juvenile idiopathic arthritis. |
| Domain | Health Sciences |
| Field | Medicine |
| OpenAlex ID | t11194 |
| Works | 416 |

## Topic papers all

Showing 15 of 416.

- [The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria](https://scholariq.org/papers/the-international-criteria-for-behcet-s-disease-icbd-a-collaborative-study-of-27/)
- [Heparin treatment in sinus venous thrombosis](https://scholariq.org/papers/heparin-treatment-in-sinus-venous-thrombosis/)
- [A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis](https://scholariq.org/papers/a-longitudinal-study-of-abnormalities-on-mri-and-disability-from-multiple/)
- [2018 update of the EULAR recommendations for the management of Behçet's syndrome](https://scholariq.org/papers/2018-update-of-the-eular-recommendations-for-the-management-of-behcet-s-syndrome/)
- [Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration](https://scholariq.org/papers/ranibizumab-versus-bevacizumab-to-treat-neovascular-age-related-macular/)
- [Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial](https://scholariq.org/papers/alternative-treatments-to-inhibit-vegf-in-age-related-choroidal/)
- [EULAR recommendations for the management of Behçet disease](https://scholariq.org/papers/eular-recommendations-for-the-management-of-behcet-disease/)
- [Standardizatlon of Vitreal inflammatory Activity in Intermediate and Posterior Uveitis](https://scholariq.org/papers/standardizatlon-of-vitreal-inflammatory-activity-in-intermediate-and-posterior/)
- [Intraocular Tuberculosis—An Update](https://scholariq.org/papers/intraocular-tuberculosis-an-update/)
- [MRI characteristics of neuromyelitis optica spectrum disorder](https://scholariq.org/papers/mri-characteristics-of-neuromyelitis-optica-spectrum-disorder/)
- [The frequency and outcome of lupus nephritis: results from an international inception cohort study](https://scholariq.org/papers/the-frequency-and-outcome-of-lupus-nephritis-results-from-an-international/)
- [A multicenter, randomized, double‐blind, placebo‐controlled trial of adjuvant methotrexate treatment for giant cell arteritis](https://scholariq.org/papers/a-multicenter-randomized-double-blind-placebo-controlled-trial-of-adjuvant/)
- [Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis](https://scholariq.org/papers/retinal-layer-segmentation-in-multiple-sclerosis-a-systematic-review-and-meta/)
- [Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci](https://scholariq.org/papers/genome-wide-association-studies-identify-il23r-il12rb2-and-il10-as-behcet-s/)
- [Polypoidal Choroidal Vasculopathy](https://scholariq.org/papers/polypoidal-choroidal-vasculopathy/)

## Topic primary papers

Showing 15 of 213.

- [The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria](https://scholariq.org/papers/the-international-criteria-for-behcet-s-disease-icbd-a-collaborative-study-of-27/)
- [2018 update of the EULAR recommendations for the management of Behçet's syndrome](https://scholariq.org/papers/2018-update-of-the-eular-recommendations-for-the-management-of-behcet-s-syndrome/)
- [EULAR recommendations for the management of Behçet disease](https://scholariq.org/papers/eular-recommendations-for-the-management-of-behcet-disease/)
- [Standardizatlon of Vitreal inflammatory Activity in Intermediate and Posterior Uveitis](https://scholariq.org/papers/standardizatlon-of-vitreal-inflammatory-activity-in-intermediate-and-posterior/)
- [Intraocular Tuberculosis—An Update](https://scholariq.org/papers/intraocular-tuberculosis-an-update/)
- [Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci](https://scholariq.org/papers/genome-wide-association-studies-identify-il23r-il12rb2-and-il10-as-behcet-s/)
- [Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial](https://scholariq.org/papers/adalimumab-for-prevention-of-uveitic-flare-in-patients-with-inactive-non/)
- [Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis](https://scholariq.org/papers/adalimumab-plus-methotrexate-for-uveitis-in-juvenile-idiopathic-arthritis/)
- [Clinical Patterns and Characteristics of Uveitis in a Tertiary Center for Uveitis in China](https://scholariq.org/papers/clinical-patterns-and-characteristics-of-uveitis-in-a-tertiary-center-for/)
- [Understanding uveitis: The impact of research on visual outcomes](https://scholariq.org/papers/understanding-uveitis-the-impact-of-research-on-visual-outcomes/)
- [Upregulated IL-23 and IL-17 in Behcet Patients with Active Uveitis](https://scholariq.org/papers/upregulated-il-23-and-il-17-in-behcet-patients-with-active-uveitis/)
- [Do tumor necrosis factor inhibitors cause uveitis? A registry‐based study](https://scholariq.org/papers/do-tumor-necrosis-factor-inhibitors-cause-uveitis-a-registry-based-study/)
- [Behçet's disease: New insights into pathophysiology, clinical features and treatment options](https://scholariq.org/papers/behcet-s-disease-new-insights-into-pathophysiology-clinical-features-and/)
- [Clinical Characteristics of Vogt–Koyanagi–Harada Syndrome in Chinese Patients](https://scholariq.org/papers/clinical-characteristics-of-vogt-koyanagi-harada-syndrome-in-chinese-patients/)
- [Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations](https://scholariq.org/papers/anti-tnf-therapy-in-the-management-of-behcet-s-disease-review-and-basis-for/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.